KLRK1 and cancer: In humans, histological studies have confirmed high and co-expression of NKG2D ligands in cancers of the breast (142, 143), colon (144, 145), gastric system (146, 147), lung (148, 149), skin (150), ovary (151, 152), pancreas (153), prostate (148, 154), and kidney (148).